Assessment of Pain of Pelvic Congestion Syndrome Treated by Coils Embolization

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-21

Study Completion Date

2021-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Summary:

Main Objective: to evaluate the efficacy of pelvic gonadal vein embolization with coils in treatment of pelvic congestion syndrome Methods: retrospective study included 25 patients in the University hospital of Brest.

The Primary Outcome Measure: To evaluate (to measure) pain relief using visual analogous scale (VAS) before and after gonadal vein embolization for pelvic congestion syndrome The Secondary Outcome Measures were to assess the impact of the treatment on specific and general symptoms through a survey.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Embolization of Pelvic Varicosities in Patients With Pelvic Congestion Syndrome

NCT03057067

Pelvic Pain Varicose Veins

TERMINATED NA

Fibered Platinum Coils vs Vascular Plugs in Pelvic Varices Embolization for the Treatment of Pelvic Congestion Syndrome

NCT02796092

Pelvic Congestion Syndrome

COMPLETED NA

Pelvic Embolisation to Reduce Recurrent Varicose Veins - Recurrent

NCT01909024

Varicose Veins Venous Reflux Pelvic Congestion Syndrome

UNKNOWN NA

The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities

NCT03652025

Venous Insufficiency

UNKNOWN NA

Pelvic Embolisation to Reduce Recurrent Varicose Veins - Primary

NCT01901731

Varicose Veins Venous Reflux

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A retrospective, non-invasive monocentric study of our Hospital 10-year registry (including data on MRI angiography and Vascular Doppler Ultrasound) of patients who have already undergone coil embolization of pelvic gonadal vein in treatment of pelvic congestion syndrome. These patients will be contacted by phone to participate in the study. An information letter will be handed out and the study protocol will be explained to the patients. After obtaining their written consent, they will be asked to fill out the study's validated questionnaire at home and return it to us through pre-paid regular mail. A face to face interview with the patient will be scheduled to assess the correlation between patient's clinical symptoms and survey results. There will be no change in patient's routine follow-up care.

All physician investigators of the study are experts in their field of medicine (e.g. interventional MRI angiography, vascular disease).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical symptoms of pelvic congestion syndrome documented by Vascular Doppler ultrasound and vascular dynamic MRI
* Failed medical treatment.
* \> 18 years \< 60 years old

Exclusion Criteria

* \< 18 years old
* Under legal guardian
* Asymptomatic pelvic congestion syndrome
* Psychiatric disorder
* Endometriosis.
* Chronic pelvic disease
* Pregnancy
* Neoplasia
* Acute intermittent porphyria

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No